These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1657763)

  • 21. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ; Guo KY; Wei HM; Song CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens.
    Reiter Z; Fischer DG; Rubinstein M
    Immunol Lett; 1988 Apr; 17(4):323-8. PubMed ID: 2453457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule.
    Roth C; Kourilsky P; Ojcius DM
    Eur J Immunol; 1994 Sep; 24(9):2110-4. PubMed ID: 8088332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
    Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
    Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
    Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
    Jewett A; Bonavida B
    Clin Immunol; 2000 Jul; 96(1):19-28. PubMed ID: 10873424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis.
    Storkus WJ; Wei M; Cresswell P; Dawson JR
    Cell Immunol; 1996 Jan; 167(1):154-6. PubMed ID: 8548840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.
    Ayalon O; Hughes EA; Cresswell P; Lee J; O'Donnell L; Pardi R; Bender JR
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2435-40. PubMed ID: 9482903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells.
    Giezeman-Smits KM; Kuppen PJ; Ensink NG; Eggermont AM; Stals F; Wonigeit K; Fleuren GJ
    Immunobiology; 1996 Aug; 195(3):286-99. PubMed ID: 8877403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis.
    Jonges LE; Giezeman-Smits KM; van Vlierberghe RL; Ensink NG; Hagenaars M; Joly E; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Immunobiology; 2000 Nov; 202(4):326-38. PubMed ID: 11131150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histocompatibility antigens and natural killer susceptibility.
    Peña J; Solana R
    Immunol Res; 1992; 11(2):133-40. PubMed ID: 1431422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I expression on human tumour cells and their susceptibility to NK lysis.
    Pena J; Solana R; Alonso MC; Santamaria M; Serrano R; Ramirez R; Carracedo J
    J Immunogenet; 1989; 16(4-5):407-12. PubMed ID: 2517951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An inducer of NKCF (NK cytotoxic factor) release: localization on target-cell membrane and initial characterization.
    Reiter Z; Loyter A; Nussbaum O; Rubinstein M
    Cell Immunol; 1992 Jul; 142(2):370-84. PubMed ID: 1377986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of mechanisms by which NK cells acquire increased cytotoxicity against class I MHC-eliminated targets.
    Sugawara S; Abo T; Itoh H; Kumagai K
    Cell Immunol; 1989 Apr; 119(2):304-16. PubMed ID: 2702694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity.
    Chovatiya N; Kaur K; Huerta-Yepez S; Chen PC; Neal A; DiBernardo G; Gumrukcu S; Memarzadeh S; Jewett A
    Cancer Immunol Immunother; 2022 Dec; 71(12):2929-2941. PubMed ID: 35507102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The skin test antigen stimulated killer (STAK) cell mediating NK like CMC is OKM1 positive and OKT3 negative.
    Tartof D; Curran JJ; Levitt D; Loken MR
    Clin Exp Immunol; 1983 Nov; 54(2):561-6. PubMed ID: 6360439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.